论文部分内容阅读
目的 :报导使用牟希亚、郭雁群发明的“绿脓杆菌 - MSHA菌毛株菌苗”,全面调查与激活人体的免疫保护状态 ,从而消除了癌症患者的免疫低下状态 ,不仅对防治严重致死性条件病原体医院感染有良好作用 ,同时对增加癌症患者的 CR率和降低其 PD率也发生着重要影响。如经“菌苗”参与治疗后 ,肺癌的条件病原体感染率由单纯化疗的 4 0 .89%降至 15 .91% ,恶性淋巴瘤的感染率由 37.2 1%下降至 17.78% ;临床 CR(完全缓解率 )分别从 6 .6 7%升至 2 5 .0 0和从 4 4 .19%升至 6 6 .87% ;临床 PD(疾病恶化 )率则从15 .5 6 %降至 4 .5 5 %和自 11.6 3%降至 0。急性白血病的感染率从 94 .12 %降至 5 8.82 %。免疫状态也明显向健康状态转变
OBJECTIVE: To report the use of “Pseudomonas aeruginosa-MSHA fimbriae vaccine” invented by Mu Xiya and Guo Yanqun to comprehensively investigate and activate the immune protection status of the human body, thus eliminating the immunocompromised condition of cancer patients. Not only is it effective against the serious lethal condition pathogens Hospital infection has a good effect, while increasing the CR rate of cancer patients and reduce its PD rate also have a significant impact. The infection rate of conditional pathogen of lung cancer decreased from 40.8% to 15.91% in chemotherapy alone, and the infection rate of malignant lymphoma decreased from 37.2% to 17.78% after treatment with “bacterin”. Clinical CR ( Complete remission rate increased from 6.67% to 25.0.0 and from 4.19% to 6.67% respectively. The clinical PD (disease progression) rate dropped from 15.56% to 4 .5 5% and from 11.6 3% to 0. The infection rate of acute leukemia dropped from 94.12% to 58.82%. Immune status also significantly changed to a healthy state